7 items found

Tags: 23- valent pneumococcal polysaccharide vaccine

Filter Results
  • dataset

    r37980778c78--0297a52cbc045961018bb276cdf38a4b

    ICER of the two cohort-approaches under 10-year implementation, using an infinite time horizon.
  • dataset

    r37980778c78--bb0a3fb7ef49fd9ac79cb229cf4821bc

    Sensitivity analysis of the main input in the cost-effectiveness for the 3 strategies.
  • dataset

    r37980778c78--f9dae7e10bcce1506edcbf7111252ebc

    Sensitivity analysis of important assumptions between PCV13 and PPV23 among elderly.
  • dataset

    Impact of time horizon on ICER in the scenario with replacement and vaccinati...

    Impact of time horizon on ICER in the scenario with replacement and vaccinating at 65 years of age.
  • dataset

    r37980778c78--15cf0f99616335a250758d6384577d61

    BackgroundStreptococcus pneumoniae causes morbidity and mortality among all ages in The Netherlands. To reduce this burden, infants in The Netherlands receive the 10-valent...
  • dataset

    Main inputs for the cost-effectiveness analysis.

    Main inputs for the cost-effectiveness analysis.
  • dataset

    The total number cases, deaths and QALYs for IPD and vaccine type CAP and the...

    Vaccination coverage 50% for both PCV13 and PPV23 and full coverage for PCV13 among children.